JESSICA HENDERSON: Open Payments
NPI 1083227060 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,180 in 66 payments from 17 companies in 2025. Trend: 2023 $740 · 2024 $1,335 · 2025 $1,180
Food & beverage: $1,180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $190 |
| Alkermes, Inc. | 11 | $186 |
| Tris Pharma Inc | 11 | $184 |
| E.R. Squibb & Sons, L.L.C. | 5 | $97 |
| Corium, LLC | 5 | $97 |
| Lundbeck LLC | 3 | $68 |
| Teva Pharmaceuticals USA, Inc. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
Products named: VRAYLAR, ARISTADA, Dyanavel XR, COBENFY, Azstarys, REXULTI, AUSTEDO XR, Auvelity.
Industry payments across MD — which companies pay providers there.
